Noile-Immune Biotech, Inc.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public
- Established
- 2015-04-01
- Employees
- 28
- Market Cap
- -
- Website
- http://www.noile-immune.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study of NIB101 in Participants With Advanced Solid Tumors
- First Posted Date
- 2022-01-14
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Noile-Immune Biotech, Inc
- Target Recruit Count
- 3
- Registration Number
- NCT05192174
- Locations
- 🇯🇵
National Cancer Center Hospital East, Kashiwa, Chiba, Japan
🇯🇵National Cancer Center Hospital, Chuo Ku, Tokyo, Japan
News
No news found